|
|
||||||||


*
Laboratory of Immunoregulation, and
Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892; and
Dipartimento di Medicina Sperimentale e Clinica, Universita degli Studi di Catanzaro, Catanzaro, Italy
Efforts to develop a protective HIV-1 vaccine have been hindered by difficulties in identifying epitopes capable of inducing broad neutralizing Ab responses. In fact, the high mutation rate occurring in HIV-1 envelope proteins and the complex structure of gp120 as an oligomer associated with gp41 result in a high degree of antigenic polymorphism. To overcome these obstacles, we screened random peptide libraries using sera from HIV-infected subjects to identify antigenic and immunogenic mimics of HIV-1 epitopes. After extensive counterscreening with HIV-negative sera, we isolated peptides specifically recognized by Abs from HIV-1-infected individuals. These peptides behaved as antigenic mimics of linear or conformational HIV-1 epitopes generated in vivo in infected subjects. Consistent with these findings, sera of simian HIV-infected monkeys also recognized the HIV-specific epitopes. The selected peptides were immunogenic in mice, where they elicited HIV-specific Abs that effectively neutralized HIV-1 isolates. These results demonstrate that pools of HIV-1 mimotopes can be selected from combinatorial peptide libraries by taking advantage of the HIV-specific Ab repertoire induced by the natural infection.
This article has been cited by other articles:
![]() |
G. Bastas, S. R. Sompuram, B. Pierce, K. Vani, and S. A. Bogen Bioinformatic Requirements for Protein Database Searching Using Predicted Epitopes from Disease-associated Antibodies Mol. Cell. Proteomics, February 1, 2008; 7(2): 247 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lico, F. Capuano, G. Renzone, M. Donini, C. Marusic, A. Scaloni, E. Benvenuto, and S. Baschieri Peptide display on Potato virus X: molecular features of the coat protein-fused peptide affecting cell-to-cell and phloem movement of chimeric virus particles. J. Gen. Virol., October 1, 2006; 87(Pt 10): 3103 - 3112. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sharma, A. Saha, S. Bhattacharjee, S. Majumdar, and S. K. Das Gupta Specific and Randomly Derived Immunoactive Peptide Mimotopes of Mycobacterial Antigens Clin. Vaccine Immunol., October 1, 2006; 13(10): 1143 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Casey, A. M. Coley, G. Street, K. Parisi, P. L. Devine, and M. Foley Peptide mimotopes selected from a random Peptide library for diagnosis of epstein-barr virus infection. J. Clin. Microbiol., March 1, 2006; 44(3): 764 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Li, F. Gao, J. R. Mascola, L. Stamatatos, V. R. Polonis, M. Koutsoukos, G. Voss, P. Goepfert, P. Gilbert, K. M. Greene, et al. Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies J. Virol., August 15, 2005; 79(16): 10108 - 10125. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Decker, F. Bibollet-Ruche, X. Wei, S. Wang, D. N. Levy, W. Wang, E. Delaporte, M. Peeters, C. A. Derdeyn, S. Allen, et al. Antigenic conservation and immunogenicity of the HIV coreceptor binding site J. Exp. Med., May 2, 2005; 201(9): 1407 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Granoff, G. R. Moe, M. M. Giuliani, J. Adu-Bobie, L. Santini, B. Brunelli, F. Piccinetti, P. Zuno-Mitchell, S. S. Lee, P. Neri, et al. A Novel Mimetic Antigen Eliciting Protective Antibody to Neisseria meningitidis J. Immunol., December 1, 2001; 167(11): 6487 - 6496. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. ENSHELL-SEIJFFERS, L. SMELYANSKI, N. VARDINON, I. YUST, and J. M. GERSHONI Dissection of the humoral immune response toward an immunodominant epitope of HIV: a model for the analysis of antibody diversity in HIV+ individuals FASEB J, October 1, 2001; 15(12): 2112 - 2120. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |